JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 180 filers reported holding JUNO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.57 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,919,000 | +5.3% | 63,851 | +3.3% | 0.02% | -20.0% |
| Q3 2017 | $2,773,000 | +65.6% | 61,808 | +10.3% | 0.02% | +47.1% |
| Q2 2017 | $1,675,000 | +29.8% | 56,054 | -3.6% | 0.02% | +30.8% |
| Q1 2017 | $1,290,000 | -3.7% | 58,129 | -18.2% | 0.01% | -13.3% |
| Q4 2016 | $1,339,000 | -35.5% | 71,036 | +2.7% | 0.02% | -48.3% |
| Q3 2016 | $2,076,000 | -33.3% | 69,184 | -14.6% | 0.03% | -27.5% |
| Q2 2016 | $3,114,000 | +4.1% | 81,012 | +3.1% | 0.04% | -2.4% |
| Q1 2016 | $2,992,000 | -18.6% | 78,550 | -6.0% | 0.04% | -8.9% |
| Q4 2015 | $3,674,000 | – | 83,550 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|